150 related articles for article (PubMed ID: 2460161)
1. Naturally occurring human antibodies against two distinct functional domains in the heavy chain of FXI/FXIa.
De La Cadena RA; Baglia FA; Johnson CA; Wenk RE; Amernick R; Walsh PN; Colman RW
Blood; 1988 Nov; 72(5):1748-54. PubMed ID: 2460161
[TBL] [Abstract][Full Text] [Related]
2. Severe factor XI deficiency caused by a Gly555 to Glu mutation (factor XI-Glu555): a cross-reactive material positive variant defective in factor IX activation.
Zivelin A; Ogawa T; Bulvik S; Landau M; Toomey JR; Lane J; Seligsohn U; Gailani D
J Thromb Haemost; 2004 Oct; 2(10):1782-9. PubMed ID: 15456490
[TBL] [Abstract][Full Text] [Related]
3. Functional domains in the heavy-chain region of factor XI: a high molecular weight kininogen-binding site and a substrate-binding site for factor IX.
Baglia FA; Sinha D; Walsh PN
Blood; 1989 Jul; 74(1):244-51. PubMed ID: 2665835
[TBL] [Abstract][Full Text] [Related]
4. Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen.
Bar Barroeta A; Marquart JA; Bakhtiari K; Meijer AB; Urbanus RT; Meijers JCM
J Thromb Haemost; 2022 Nov; 20(11):2538-2549. PubMed ID: 35815349
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein.
Renné T; Gailani D; Meijers JC; Müller-Esterl W
J Biol Chem; 2002 Feb; 277(7):4892-9. PubMed ID: 11733491
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the factor XI variant Arg184Gly suggests a structural basis for factor IX binding to factor XIa.
Geng Y; Verhamme IM; Sun MF; Bajaj SP; Emsley J; Gailani D
J Thromb Haemost; 2013 Jul; 11(7):1374-84. PubMed ID: 23617568
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen-deuterium exchange mass spectrometry highlights conformational changes induced by factor XI activation and binding of factor IX to factor XIa.
Bar Barroeta A; van Galen J; Stroo I; Marquart JA; Meijer AB; Meijers JCM
J Thromb Haemost; 2019 Dec; 17(12):2047-2055. PubMed ID: 31519061
[TBL] [Abstract][Full Text] [Related]
8. Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates.
Puy C; Tucker EI; Wong ZC; Gailani D; Smith SA; Choi SH; Morrissey JH; Gruber A; McCarty OJ
J Thromb Haemost; 2013 Jul; 11(7):1341-52. PubMed ID: 23659638
[TBL] [Abstract][Full Text] [Related]
9. Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX.
Visser M; van Oerle R; Ten Cate H; Laux V; Mackman N; Heitmeier S; Spronk HMH
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):103-111. PubMed ID: 31766871
[TBL] [Abstract][Full Text] [Related]
10. Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation.
Gailani D; Broze GJ
Blood; 1993 Aug; 82(3):813-9. PubMed ID: 8338946
[TBL] [Abstract][Full Text] [Related]
11. Evidence for factor IX-independent roles for factor XIa in blood coagulation.
Matafonov A; Cheng Q; Geng Y; Verhamme IM; Umunakwe O; Tucker EI; Sun MF; Serebrov V; Gruber A; Gailani D
J Thromb Haemost; 2013 Dec; 11(12):2118-27. PubMed ID: 24152424
[TBL] [Abstract][Full Text] [Related]
12. Factor XI contributes to thrombin generation in the absence of factor XII.
Kravtsov DV; Matafonov A; Tucker EI; Sun MF; Walsh PN; Gruber A; Gailani D
Blood; 2009 Jul; 114(2):452-8. PubMed ID: 19351955
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a heparin binding site on the heavy chain of factor XI.
Zhao M; Abdel-Razek T; Sun MF; Gailani D
J Biol Chem; 1998 Nov; 273(47):31153-9. PubMed ID: 9813019
[TBL] [Abstract][Full Text] [Related]
14. High molecular weight kininogen interactions with the homologs prekallikrein and factor XI: importance to surface-induced coagulation.
Mohammed BM; Sun MF; Cheng Q; Litvak M; McCrae KR; Emsley J; McCarty OJT; Gailani D
J Thromb Haemost; 2024 Jan; 22(1):225-237. PubMed ID: 37813198
[TBL] [Abstract][Full Text] [Related]
15. Factor XI anion-binding sites are required for productive interactions with polyphosphate.
Geng Y; Verhamme IM; Smith SA; Cheng Q; Sun M; Sheehan JP; Morrissey JH; Gailani D
J Thromb Haemost; 2013 Nov; 11(11):2020-8. PubMed ID: 24118982
[TBL] [Abstract][Full Text] [Related]
16. The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells.
Mahdi F; Shariat-Madar Z; Schmaier AH
J Biol Chem; 2003 Nov; 278(45):43983-90. PubMed ID: 12944405
[TBL] [Abstract][Full Text] [Related]
17. The mechanism underlying activation of factor IX by factor XIa.
Gailani D; Geng Y; Verhamme I; Sun MF; Bajaj SP; Messer A; Emsley J
Thromb Res; 2014 May; 133 Suppl 1(0 1):S48-51. PubMed ID: 24759143
[TBL] [Abstract][Full Text] [Related]
18. Productive recognition of factor IX by factor XIa exosites requires disulfide linkage between heavy and light chains of factor XIa.
Marcinkiewicz MM; Sinha D; Walsh PN
J Biol Chem; 2012 Feb; 287(9):6187-95. PubMed ID: 22207756
[TBL] [Abstract][Full Text] [Related]
19. Role of platelets in regulating activated coagulation factor XI activity.
Reitsma SE; Pang J; Raghunathan V; Shatzel JJ; Lorentz CU; Tucker EI; Gruber A; Gailani D; McCarty OJT; Puy C
Am J Physiol Cell Physiol; 2021 Mar; 320(3):C365-C374. PubMed ID: 33471623
[TBL] [Abstract][Full Text] [Related]
20. The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface.
DeLa Cadena RA; Colman RW
Protein Sci; 1992 Jan; 1(1):151-60. PubMed ID: 1304876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
